The Opportunity
A top five pharma company needed to reinvent its patient engagement program, geared toward rare disease patients taking complex medications.
The company tasked SPRIM with uncovering the best solutions to drive compliance.
A top five pharma company needed to reinvent its patient engagement program, geared toward rare disease patients taking complex medications.
The company tasked SPRIM with uncovering the best solutions to drive compliance.
SPRIM first conducted a competitive analysis through primary and secondary research to compare the client’s engagement program with its largest competitors in multiple markets. With this intel, SPRIM found opportunities for the client to not only improve its program, but to also become the market leader in patient engagement.
SPRIM conducted interviews with dozens of internal and external players with insights into the client’s patient engagement operations. This helped identify problem areas and gauge attitudes towards the current programs.
Using the research conducted, SPRIM identified key concerns and common areas of weakness where patients felt left behind. SPRIM collaborated with the client, providing comprehensive strategic guidelines for improvements.
The client is using SPRIM’s findings to implement strategic changes and patient-centric practices to increase medication adherence.